000 | 01994 a2200541 4500 | ||
---|---|---|---|
005 | 20250513113902.0 | ||
264 | 0 | _c19970627 | |
008 | 199706s 0 0 eng d | ||
022 | _a1053-2498 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aWagner, K | |
245 | 0 | 0 |
_aNew-onset diabetes mellitus in pediatric thoracic organ recipients receiving tacrolimus-based immunosuppression. _h[electronic resource] |
260 |
_bThe Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation _cMar 1997 |
||
300 |
_a275-82 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAdolescent |
650 | 0 | 4 |
_aAdrenal Cortex Hormones _xadministration & dosage |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aChild |
650 | 0 | 4 | _aChild, Preschool |
650 | 0 | 4 |
_aCystic Fibrosis _xsurgery |
650 | 0 | 4 |
_aDiabetes Mellitus, Type 1 _xchemically induced |
650 | 0 | 4 | _aDose-Response Relationship, Drug |
650 | 0 | 4 | _aDrug Administration Schedule |
650 | 0 | 4 | _aDrug Therapy, Combination |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aFollow-Up Studies |
650 | 0 | 4 | _aGlucose Tolerance Test |
650 | 0 | 4 |
_aHeart Transplantation _ximmunology |
650 | 0 | 4 |
_aHeart-Lung Transplantation _ximmunology |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aImmunosuppressive Agents _xadministration & dosage |
650 | 0 | 4 | _aInfant |
650 | 0 | 4 |
_aIslets of Langerhans _xdrug effects |
650 | 0 | 4 |
_aLung Transplantation _ximmunology |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aPostoperative Complications _xchemically induced |
650 | 0 | 4 | _aRisk Factors |
650 | 0 | 4 |
_aTacrolimus _xadministration & dosage |
700 | 1 | _aWebber, S A | |
700 | 1 | _aKurland, G | |
700 | 1 | _aBoyle, G J | |
700 | 1 | _aMiller, S A | |
700 | 1 | _aCipriani, L | |
700 | 1 | _aGriffith, B P | |
700 | 1 | _aFricker, F J | |
773 | 0 |
_tThe Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation _gvol. 16 _gno. 3 _gp. 275-82 |
|
999 |
_c9071826 _d9071826 |